Study | Country | Years Studied | Population/Setting | Type of Study | Type | Rate | Age Standardized | Registry-Based |
---|---|---|---|---|---|---|---|---|
Population-based studies of THA and TKA | ||||||||
1. Ingvarsson, 1999 [7] | Iceland | 1982-1996 | Population-based | Cohort | THA for osteoarthritis (OA) | 1996: 40-49 yrs: 17/100,000 50-59 yrs: 97/100,000 60-69 yrs: 333/100,000 70-79 yrs: 499/100,000 80+ yrs: 314/100,000 |
Yes | No |
2. Lohmander 2006 [8] | Denmark, Finland, Iceland, Norway, Sweden | 1996-2000 | Population-based | Cohort | Primary THA for primary hip OA | All: 61-84/100,000 F: 60-92/100,000 M: 48-75/100,000 |
Yes | Yes |
3. Pedersen 2005 [9] | Denmark | 1996-2002 | Population-based | Cohort | Primary and revision THA | Incidence rate, 1996: Prim THA: 101/100,000 Rev THA: 19/100,000 Incidence rate, 2002: Prim THA: 131/100,000 Rev THA: 21/100,000 |
Yes | Yes |
4. Steel 2006 [10] | U.K. | 2002 | Population-based: people ≥60 yrs, representative of the population of England interviewed | Cross-sectional | THA or TKA | Lifetime prevalence of THA or TKA : F: 6% M: 5% |
No | No |
5. Robertsson 2000 [11] | Sweden | 1976-1997 | Population-based | Cohort | primary and revision TKAs | Incidence rate, 1976: Prim TKA, all: 13/100,000 F: 18/100,000 M: 7/100,000 Incidence rate, 1997: Prim TKA, all: 63/100,000 F: 69/100,000 M: 35/100,000 |
Yes | Yes |
6. Coyte 1997 [12] | Ontario, Canada | 1984-1990 | TKAs performed in Ontario from the Canadian Institute for Health Information | Cohort | TKA | Utilization rates: 1984 to 1990 F: 24/100,000 to 52/100,000 M: 11/100,000 to 33/100,000 |
Yes | No |
7. Melton 1982 [25] | Olmsted County, U.S. | 1969-1980 | THAs performed in Olmsted county, Minnesota | Cohort | THA | Biennial Incidence rates: 1969-1970: 20/100,000 1971-1972: 45/100,000 1973-74: 48/100,000 1975-76: 43/100,000 1977-78: 54/100,000 1979-80: 54/100,000 F: 52/100,000 M: 34/100,000 |
Yes | Yes |
8. Johnsson 1987 [26] | Southern Sweden | 1981-82 | THA in nine Southern most units in Sweden | Cohorts | THA | Hip Replacement (THA and hemi-arthroplasty): 26/10,000 for adults aged 49 and older |
Yes | Yes |
9. Wells 2002 [13] | Australia | 1994-1998 | Population-based: all Australians underwent THA and TKA for the principal diagnosis of osteoarthritis |
Cohort | THA and TKA for OA | 1994: Prim THA: 51/100,000 Prim TKA: 56/100,000 1998: Prim THA: 61/100,000 Prim TKA: 77/100,000 |
No | No |
Registry/National Database Based THA Studies | ||||||||
10. Abbott 2003 [14] | U.S. | 1995-1999 | 2000 United States Renal Data System | Cohort | THA | 35 per 10,000 person-years compared to 5.3/10,000 in the general population |
No | No |
11. Clark 2001 [15] | U.S. | 1987-1996 | Army aviators 214,300 aviator-years of observation |
Cohort | THA | 0.05/1,000 aviator years of observation (11 aviators with 14 THAs) |
No | Yes |
12. Kim 2008 [16] | South Korea | 2002-2006 | National Database with reimbursement records from all South Korean medical facilities |
Cross-sectional | THA | 2002: F: 1.7/100,000 M: 1.4/100,000 2005: F: 3.1/100,000 M: 2/100,000 |
Yes | Yes |
13. Birrell 1999 , [27] | England | 1996 | Hospital Episode System (HES) for identification of all THAs |
Cross-sectional | THA | 1996: All: 87/100,000 F: 109/100,000 M: 65/100,000 |
No | No |
14. Hoaglund 1995 und, F. T. [28] |
San Francisco, U.S. | 1984-1988 | Hospital records from 17 hospitals in “San Francisco country” |
Cross-sectional | THA for primary hip OA | White: 76/100,000 Black: 35/100,000 Hispanic: 13/100,000 Filipino: 7/100,000 Japanese: 17/100,000 Chinese: 8/100,000 |
Yes | No |
15. Puolakka 2001 [29] | Finland | 1999 | Cohort | THA | 1999: Prim THA: 93/100,000Rev THA: 23/100,000 | No | Yes | |
Registry/National Database Based TKA Studies | ||||||||
16. Mehrotra 2005 [17] | U.S. | 1990-2000 | Wisconsin Inpatient Hospital Database for Wisconsin residents ≥45 years | Cross-sectional | Primary TKA | 1990: All (age-standardized): 162/100,00 F: 30/100,000 M: 23/100,000 2000: All (age-standardized): : 294/100,000 F: 46/100,000 M: 35/1000,000 |
Yes | No |
17. Kim 2008 [18] | South Korea | 2002-2005 | National Database with reimbursement records from all South Korean medical facilities | Cross-sectional | TKA | 2002: F: 85/100,000 M: 10/100,000 2005: F: 157/100,000 M: 20/100,000 |
Yes | Yes |
18. Juni 2003 [19] | U.K. | 1994-95 | Survey of 40 clinical practices in Somerset and Avon, UK of 26,046 people | Cross-Sectional | TKA | 8.4/1,000 for TKA for subjects ≥35 years M: 5.5/1,000 F: 10.7/1,000 |
No | No |
19. Centers for Disease Control and Prevention 2009 [20] | U.S. | 2000 & 2006 | Medicare enrollees aged ≥65 years, not members of Health Maintenance organizations and entitled to Medicare part A 2000: 26,585,955 2006: 28,382,683 |
Cross-sectional | TKA | 2000: 5.5/1,000 2006: 8.7/1,000 Racial Disparity: Whites: 5.7/1,000 in 2000 and 9.2/1,000 in 2006 Blacks: 3.6/1,000 in 2000 and 5.6/1,000 in 2006 Male: 4.6 in 2000, 7.3 in 2006 Female: 6.1 in 2000, 9.8 in 2006 |
Yes | No |
Registry/National Database Based THA and TKA Studies | ||||||||
20. Jarvholm 2007 [21] | Sweden | 1960-1992 | Construction worker cohort participating in national health control program from |
Cohort | THA & TKA | Ranged between professions from 447-857/million person-years for THA, 123-407/million person-years for TKA |
Yes | Yes |
21. Kurtz 2007 [22] | U.S. | 1990-2002 | National Hospital Discharge Survey (NHDS), a representative sample of all non-federal non-military in-patient facilities |
Cross-sectional | THA and TKA | 1990: Prim THA: 47/100,000 Rev THA: 9.5/100,000 Prim TKA: 51/100,000 Rev TKA: 4.7/100,000 2002: Prim THA: 69/100,000 Rev THA: 15.2/100,000 Prim TKA: 136/100,000 Rev TKA: 12.5/100,000 |
Yes | No |
22. Melzer 2003 [23] | U.S. | 1993 | 1993 National Mortality Follow back Survey in people ≥65 years, who had THA or TKA <1 year from their death |
Cross-sectional | TKA and THA | Prevalence: THA: 15.5% TKA: 6% |
No | No |
23. Wells 2004 [24] | Australia | 1994-2002 | Male Veterans compared with male civilians for THA and TKA for OA in Southern Australia |
Cohort | THA and TKA for OA |
THA: Standardized morbidity ratio (SMR)- 0.715 TKA: SMR-0.987 |
Yes | Yes |
24. Havelin 2000 [30] | Norway | 1997 | Norwegian register established 1988 | Cohort | THA | 1997: prim THA: 120/100,000 Rev THA: 24/100,000 Prim TKA: 34/100,000 |